TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -1 | -6 | 8 | 37 | 4 | 70 | 19 |
| P | %wins | 0 | 0 | 100 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/10/20 16:20 | 12/27/19 | LQDA | Liquidia Technologies Inc | DE | Health | MdEq | Surgical & Medical Instrument | Canaan VIII LP | CT | T | P | 1,000 | 3.13 | 0 | 319 | 12 | 2,917 | D | |||||||||||||||
8/1/18 17:12 | 7/30/18 | LQDA | Liquidia Technologies Inc | DE | Health | MdEq | Surgical & Medical Instrument | Canaan VIII LP | CT | T | P.d | 8,000 | 11.00 | 0 | 727 | 40 | 2,563 | D | |||||||||||||||
10/8/14 16:18 | 10/8/14 | DERM | Dermira, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Canaan VIII LP | CT | DT | P.d | 788 | 16.00 | 33 | 49 | 2 | 2,500 | D | -1 | -6 | 8 | 37 | 4 | 70 | |||||||||
7/27/12 14:26 | 7/24/12 | DRTX | Durata Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Canaan VIII LP | CT | DT | P.ad | 5,000 | 9.00 | 0 | 556 | 41 | 1,902 | D | |||||||||||||||
7/26/12 19:59 | 7/24/12 | DRTX | Durata Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Canaan VIII LP | CT | DT | P.d | 5,000 | 9.00 | 0 | 556 | 41 | 1,902 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |